(MENAFN) Roche Holding is in talks to buy the almost 40 percent stake in Japan's Chugai Pharmaceutical Company Limited that it does not already own for about USD10 billion, Gulf Daily News reported.
The Swiss group could announce a deal to take full control of its Japanese partner for oncology and arthritis drugs as early as next week, although no final decision has been made, Bloomberg reported.
Acquiring the rest of Chugai would be a considerably larger purchase but would still be very manageable for Roche, which has a market value of about USD250 billion.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.